BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 2168572)

  • 1. Role of chromatin structure in transcriptional regulation of MMTV LTR hormone-dependent promoter.
    Richard-Foy H; Adom J; Carr K; Gouilleux F; Marsaud V; Redeuilh G; Sabbah M; Sola B
    Rev Esp Fisiol; 1990 Mar; 46(1):31-7. PubMed ID: 2168572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
    Härtig E; Cato AC
    Cell Mol Biol Res; 1994; 40(7-8):643-52. PubMed ID: 7787882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxA1 binding to the MMTV LTR modulates chromatin structure and transcription.
    Holmqvist PH; Belikov S; Zaret KS; Wrange O
    Exp Cell Res; 2005 Apr; 304(2):593-603. PubMed ID: 15748903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome.
    Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT
    Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin structure of hormono-dependent promoters.
    Adom J; Carr KD; Gouilleux F; Marsaud V; Richard-Foy H
    J Steroid Biochem Mol Biol; 1991; 40(1-3):325-32. PubMed ID: 1683563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
    Mulholland NM; Soeth E; Smith CL
    Oncogene; 2003 Jul; 22(31):4807-18. PubMed ID: 12894222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter by the androgen and glucocorticoid receptor.
    List HJ; Lozano C; Lu J; Danielsen M; Wellstein A; Riegel AT
    Exp Cell Res; 1999 Aug; 250(2):414-22. PubMed ID: 10413595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization of multicomponent transcription factor complexes on chromatin and nonnucleosomal templates in vivo.
    Archer TK; Lee HL
    Methods; 1997 Feb; 11(2):235-45. PubMed ID: 8993036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of gene targeting and chromatin remodelling by nuclear receptors.
    Hager GL; Fletcher TM; Xiao N; Baumann CT; Müller WG; McNally JG
    Biochem Soc Trans; 2000; 28(4):405-10. PubMed ID: 10961929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse mammary tumor virus superantigen expression is reduced by glucocorticoid treatment.
    Tovar Sepúlveda VA; Berdel B; Coffin JM; Reuss FU
    Virology; 2000 Sep; 275(1):98-106. PubMed ID: 11017791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone H1 enhances synergistic activation of the MMTV promoter in chromatin.
    Koop R; Di Croce L; Beato M
    EMBO J; 2003 Feb; 22(3):588-99. PubMed ID: 12554659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mouse mammary tumour virus promoter positioned on a tetramer of histones H3 and H4 binds nuclear factor 1 and OTF1.
    Spangenberg C; Eisfeld K; Stünkel W; Luger K; Flaus A; Richmond TJ; Truss M; Beato M
    J Mol Biol; 1998 May; 278(4):725-39. PubMed ID: 9614938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene mediated repression of glucocorticoid hormone response elements and glucocorticoid receptor levels.
    Jaggi R; Höck W; Ziemiecki A; Klemenz R; Friis R; Groner B
    Cancer Res; 1989 Apr; 49(8 Suppl):2266s-2274s. PubMed ID: 2564809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: an explanation for trichostatin A effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter.
    List HJ; Smith CL; Rodriguez O; Danielsen M; Riegel AT
    Exp Cell Res; 1999 Nov; 252(2):471-8. PubMed ID: 10527637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid hormone receptor status defines the MMTV promoter chromatin structure in vivo.
    Archer TK; Fryer CJ; Lee HL; Zaniewski E; Liang T; Mymryk JS
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):421-9. PubMed ID: 7626491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone-induced nucleosome positioning in the MMTV promoter is reversible.
    Belikov S; Gelius B; Wrange O
    EMBO J; 2001 Jun; 20(11):2802-11. PubMed ID: 11387213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter.
    Lee HL; Archer TK
    EMBO J; 1998 Mar; 17(5):1454-66. PubMed ID: 9482742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembly of glucocorticoid receptor and c-JUN homodimer on the promoter of mouse mammary tumor virus-long terminal repeat is influenced by order of addition.
    Hsu TC; Melchiorre LP; Maksymowych AB; Kmiec E; Litwack G
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1260-6. PubMed ID: 8280142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone acetylation characterizes chromatin presetting by NF1 and Oct1 and enhances glucocorticoid receptor binding to the MMTV promoter.
    Astrand C; Belikov S; Wrange O
    Exp Cell Res; 2009 Sep; 315(15):2604-15. PubMed ID: 19463811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids regulate expression of the v-mycOK10 oncogene in a murine retroviral vector with chimeric MoMuLV-MMTV LTRs.
    Jacquemin-Sablon H; Bogenberger J
    Biochem Int; 1990; 20(4):669-79. PubMed ID: 2162166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.